Further Information
Applications Description:
The antibody may be used in ELISA and IAC.
Application notes
Depending on conjugate: dilution 1/15,000 . (The titer is defined as the dilution that gives 50 % of the absorbance from the maximum absorbance when tested with ELISA).
Suggested concentration to use in ELISA: 1/15,000 from the delivered solution. Plates are coated with 400 ng/ml BSA-conjugated C6-alkylphenol. HRP-conjugated anti-rabbit IgG as a tracer 1/8,000
Clofibrate is a drug used for the treatment of cardiovascular diseases as a lipid-lowering agent. It is found in the water environment in relatively high concentrations, especially in the neighbourhood of large cities and hospitals. It is rapidly degraded to clofibric acid.
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
This product contains sodium azide. To prevent formation of toxic vapors, do not mix with strong acidic solutions. To prevent formation of potentially explosive metallic azides in metal plumbing, always wash into drain with copious quantities of water.
This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.
Toxic Compounds
Each vial contains 0.5 ml of purified (caprylic acid) Rabbit Polyclonal IgG
BSA-clofibric acid conjugate
Each vial contains 0.5 ml of purified (caprylic acid) Rabbit Polyclonal IgG
Rabbit immune serum, purified by caprylic acid extraction.
Cross Reactivity
2,4-DB 18%
fenitrothion 13%
Bezafibrate 11%
Fenofibrate 6%
Clofibrate 100%
Clofibrinic acid 4%
Chlorpyriphos 3%
MCPA-Na 3%
Mecoprop 2%
2,4,5-T 1%
2,4-D 1%
2,4-DP 1%
Ciprofibrate 1%
Gemfibrozil 1%
MCPA 1%
Pirimifos-ethyl 1%
Diclofenac <0.1%
Erythromycine <0.1%
Propranolol <0.1%
Immunogen: BSA-clofibric acid conjugate, Target: Clofibrate, CAS no.: 637-07-0, Solubility: Organic solvents
